Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT.

A Tichelli; H Schrezenmeier; G Socie; J Marsh; A Bacigalupo; U Duehrsen; A Franzke; M Hallek; E Thiel; Martin Wilhelm; B Hochsmann; A Barrois; K Champion; JR Passweg

Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT.

A Tichelli, H Schrezenmeier, G Socie, J Marsh, A Bacigalupo, U Duehrsen, A Franzke, M Hallek, E Thiel, Martin Wilhelm, B Hochsmann, A Barrois, K Champion, JR Passweg

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Abstract (Journal) › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	205-205
Journal	BLOOD
Volume	114
Issue number	22
Publication status	Published - 2009
Event	51st Annual Meeting and Exposition of the American-Society-of-Hematology - New Orleans, LA Duration: 5 Dec 2009 → 8 Dec 2009

Cite this

Tichelli, A., Schrezenmeier, H., Socie, G., Marsh, J., Bacigalupo, A., Duehrsen, U., Franzke, A., Hallek, M., Thiel, E., Wilhelm, M., Hochsmann, B., Barrois, A., Champion, K., & Passweg, JR. (2009). Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT. BLOOD , 114(22), 205-205.

Tichelli, A ; Schrezenmeier, H ; Socie, G et al. / Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT. In: BLOOD 2009 ; Vol. 114, No. 22. pp. 205-205.

@article{c27a71de28554523ab9e5f30ba1bb278,

title = "Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT.",

author = "A Tichelli and H Schrezenmeier and G Socie and J Marsh and A Bacigalupo and U Duehrsen and A Franzke and M Hallek and E Thiel and Martin Wilhelm and B Hochsmann and A Barrois and K Champion and JR Passweg",

year = "2009",

language = "English",

volume = "114",

pages = "205--205",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "22",

note = "51st Annual Meeting and Exposition of the American-Society-of-Hematology ; Conference date: 05-12-2009 Through 08-12-2009",

}

Tichelli, A, Schrezenmeier, H, Socie, G, Marsh, J, Bacigalupo, A, Duehrsen, U, Franzke, A, Hallek, M, Thiel, E, Wilhelm, M, Hochsmann, B, Barrois, A, Champion, K & Passweg, JR 2009, 'Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT.', BLOOD , vol. 114, no. 22, pp. 205-205.

Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT. / Tichelli, A; Schrezenmeier, H; Socie, G et al.
In: BLOOD , Vol. 114, No. 22, 2009, p. 205-205.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT.

AU - Tichelli, A

AU - Schrezenmeier, H

AU - Socie, G

AU - Marsh, J

AU - Bacigalupo, A

AU - Duehrsen, U

AU - Franzke, A

AU - Hallek, M

AU - Thiel, E

AU - Wilhelm, Martin

AU - Hochsmann, B

AU - Barrois, A

AU - Champion, K

AU - Passweg, JR

PY - 2009

Y1 - 2009

M3 - Abstract (Journal)

SN - 0006-4971

VL - 114

SP - 205

EP - 205

JO - BLOOD

JF - BLOOD

IS - 22

T2 - 51st Annual Meeting and Exposition of the American-Society-of-Hematology

Y2 - 5 December 2009 through 8 December 2009

ER -

Tichelli A, Schrezenmeier H, Socie G, Marsh J, Bacigalupo A, Duehrsen U et al. Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT. BLOOD . 2009;114(22):205-205.